Dr. Charles A. Carter named Department of Pharmaceutical & Clinical Sciences chair

On Jan. 1, the departments of Clinical Research and Pharmaceutical Sciences merged into a single department called the Department of Pharmaceutical & Clinical Sciences (PCS). Dr. Charles A. Carter served as the interim chair, helping launch and lead the initial transition phase.

On July 1, he was appointed as the new department chair.

In their recommendation letter to Dean Michael L. Adams, the search committee highlighted the energy, vision, and positivity Carter brought to his work in leading the department and to the College. “The committee members stated that his work during the past six months as interim in the newly created department was a ‘much higher threshold than an interview,’” Adams concluded.

Originally from Kenmore, New York, Carter moved to North Carolina in 1996. He completed his Bachelor of Science from State University of New York Buffalo, Doctor of Pharmacy from University of Tennessee Center for Health Sciences, and Master of Business Administration from Christian Brothers University. He also completed a residency in Bioinformatics and Drug Information and a Fellowship in Research Design Methodology.

“Dr. Carter embodies the mission and spirit of Campbell University.”

Carter joined the Campbell University family in August 2015. His initial appointment was as an associate professor in the Department of Clinical Research. He has taught in the Bachelor of Science in Clinical Research (BSCR), Master of Science in Clinical Research (MSCR), Doctor of Pharmacy (PharmD) curricula, as well as Interprofessional Education classes and courses. In addition to his teaching responsibilities, Carter mentors and advises students on their educational and post-graduate journeys. He also advises student-led organizations on campus including the Graduate Clinical Research Organization (GCRO), Industry Pharmacists Association (IPHO), and Kappa Psi Pharmaceutical Fraternity.

Prior to joining the College of Pharmacy & Health Sciences (CPHS), Carter served as the Executive Director, Medical Affairs of Salix Pharmaceuticals, Inc. in Raleigh, North Carolina from 2012 to 2015. From 1994 to 2012, he founded and operated Pharmaceutical Strategic Initiatives, LLC and focused his energies on the company’s vision and services. Pharmaceutical Strategic Initiatives was a leading provider of strategic consulting, clinical research design and strategy, regulatory preparation, medical and scientific content creation, health outcomes research, key opinion leader and advocacy development. Clients of Pharmaceutical Strategic Initiatives included 28 pharmaceutical and medical device companies. 

Carter formerly served as the Director of Research and Clinical Services at National Pharmacotherapy Institute located in Memphis, Tennessee. He has served as an investigator in more than 30 Phase 3, Phase 4, and health economics and outcomes research studies. 

Dr. Scott Asbill, associate dean of Academic Affairs, professor of Pharmaceutics, and senior chair search committee member, shared, “Dr. Carter embodies the mission and spirit of Campbell University. He has served as the interim chair for approximately six months and has done a tremendous job moving the department forward.”

Carter possesses a servant attitude and aspires to demonstrate that to those he encounters. When asked why he accepted the chair position he said, “I feel called to serve, so I’m serving.” Carter loves working at Campbell and is excited about his new responsibilities and the merging of departments.